Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
44,150
-1,900 (-4.13%)
Oct 10, 2025, 3:30 PM KST
-4.13%
Market Cap537.75B
Revenue (ttm)813.69B
Net Income (ttm)16.24B
Shares Out12.18M
EPS (ttm)1,332.95
PE Ratio33.12
Forward PEn/a
Dividend260.00 (0.56%)
Ex-Dividend DateAug 20, 2025
Volume71,810
Average Volume57,304
Open46,600
Previous Close46,050
Day's Range43,850 - 46,600
52-Week Range27,600 - 54,900
Beta0.99
RSI44.78
Earnings DateNov 12, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.

Financial Statements

News

There is no news available yet.